Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Net Margin (2020 - 2025)

NeuroPace has reported Net Margin over the past 6 years, most recently at 10.26% for Q4 2025.

  • Quarterly results put Net Margin at 10.26% for Q4 2025, up 1379.0% from a year ago — trailing twelve months through Dec 2025 was 20.98% (up 1336.0% YoY), and the annual figure for FY2025 was 20.98%, up 1336.0%.
  • Net Margin for Q4 2025 was 10.26% at NeuroPace, up from 13.08% in the prior quarter.
  • Over the last five years, Net Margin for NPCE hit a ceiling of 10.26% in Q4 2025 and a floor of 123.58% in Q2 2022.
  • Median Net Margin over the past 5 years was 50.01% (2021), compared with a mean of 56.01%.
  • Biggest five-year swings in Net Margin: plummeted -7308bps in 2022 and later soared 6758bps in 2023.
  • NeuroPace's Net Margin stood at 97.22% in 2021, then grew by 12bps to 86.01% in 2022, then surged by 58bps to 35.89% in 2023, then surged by 33bps to 24.06% in 2024, then surged by 57bps to 10.26% in 2025.
  • The last three reported values for Net Margin were 10.26% (Q4 2025), 13.08% (Q3 2025), and 34.72% (Q2 2025) per Business Quant data.